VEGDURIS Trademark

Trademark Overview

On Thursday, January 20, 2022, a trademark application was filed for VEGDURIS with the United States Patent and Trademark Office. The USPTO has given the VEGDURIS trademark a serial number of 97229961. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by AstraZeneca AB. The VEGDURIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
vegduris

General Information

Serial Number97229961
Word MarkVEGDURIS
Filing DateThursday, January 20, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, January 24, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Monday, June 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 14, 2023SOU EXTENSION 1 FILED
Tuesday, March 14, 2023SOU EXTENSION 1 GRANTED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 2 FILED
Monday, September 18, 2023SOU EXTENSION 2 GRANTED
Monday, March 11, 2024SOU EXTENSION 3 FILED
Monday, March 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 4 FILED
Wednesday, September 11, 2024SOU EXTENSION 4 GRANTED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

vegduris pharmaceutical substances preparations disorders diseases treatment infection hematological inflammation autoimmune